Wenbin Jiang - Feb 28, 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
President and CEO, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Wenbin Jiang
Stock symbol
CTKB
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 04:57 PM
Previous filing
Feb 9, 2022
Next filing
Mar 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (Right to Buy) Award $0 +163K $0.00 163K Feb 28, 2022 Common Stock 163K $13.64 Direct F1
transaction CTKB Restricted Stock Units Award $0 +108K $0.00 108K Feb 28, 2022 Common Stock 108K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly over four years from the vesting commencement date of January 1, 2022. The option becomes fully vested on January 1, 2026.
F2 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F3 The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.